These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36378251)

  • 1. Cardiac magnetic resonance radiomics for disease classification.
    Zhang X; Cui C; Zhao S; Xie L; Tian Y
    Eur Radiol; 2023 Apr; 33(4):2312-2323. PubMed ID: 36378251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of Cine-cardiac Magnetic Resonance Radiomics and Machine Learning for Differentiating Ischemic and Dilated Cardiomyopathy.
    Deng J; Zhou L; Li Y; Yu Y; Zhang J; Liao B; Luo G; Tian J; Zhou H; Tang H
    Acad Radiol; 2024 Jul; 31(7):2704-2714. PubMed ID: 38704286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial intelligence study on left ventricular function among normal individuals, hypertrophic cardiomyopathy and dilated cardiomyopathy patients using 1.5T cardiac cine MR images obtained by SSFP sequence.
    Guo J; Lu H; Chen Y; Zeng M; Jin H
    Br J Radiol; 2022 May; 95(1133):20201060. PubMed ID: 35084208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systolic myocardial volume gain in dilated, hypertrophied and normal heart. CMR study.
    Mazurkiewicz Ł; Orłowska-Baranowska E; Petryka J; Śpiewak M; Gawor M; Miłosz-Wieczorek B; Werys K; Małek ŁA; Marczak M; Grzybowski J
    Clin Radiol; 2017 Apr; 72(4):286-292. PubMed ID: 28069158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomics-Based Classification of Left Ventricular Non-compaction, Hypertrophic Cardiomyopathy, and Dilated Cardiomyopathy in Cardiovascular Magnetic Resonance.
    Izquierdo C; Casas G; Martin-Isla C; Campello VM; Guala A; Gkontra P; Rodríguez-Palomares JF; Lekadir K
    Front Cardiovasc Med; 2021; 8():764312. PubMed ID: 34778415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine learning of native T1 mapping radiomics for classification of hypertrophic cardiomyopathy phenotypes.
    Antonopoulos AS; Boutsikou M; Simantiris S; Angelopoulos A; Lazaros G; Panagiotopoulos I; Oikonomou E; Kanoupaki M; Tousoulis D; Mohiaddin RH; Tsioufis K; Vlachopoulos C
    Sci Rep; 2021 Dec; 11(1):23596. PubMed ID: 34880319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating between cardiac amyloidosis and hypertrophic cardiomyopathy on non-contrast cine-magnetic resonance images using machine learning-based radiomics.
    Jiang S; Zhang L; Wang J; Li X; Hu S; Fu Y; Wang X; Hao S; Hu C
    Front Cardiovasc Med; 2022; 9():1001269. PubMed ID: 36386316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac magnetic resonance and galectin-3 level as predictors of prognostic outcomes for non-ischemic cardiomyopathy patients.
    Hu DJ; Xu J; Du W; Zhang JX; Zhong M; Zhou YN
    Int J Cardiovasc Imaging; 2016 Dec; 32(12):1725-1733. PubMed ID: 27566192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial extracellular volume fraction measurements with MOLLI 5(3)3 by cardiovascular MRI for the discrimination of healthy volunteers from dilated and hypertrophic cardiomyopathy patients.
    Cui Y; Chen Y; Cao Y; Liu J; Song J; Zhang S; Kong X; Han P; Shi H
    Clin Radiol; 2019 Sep; 74(9):732.e9-732.e16. PubMed ID: 31122714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Myocardial Microstructural Dynamics by In Vivo Diffusion Tensor Cardiac Magnetic Resonance.
    Nielles-Vallespin S; Khalique Z; Ferreira PF; de Silva R; Scott AD; Kilner P; McGill LA; Giannakidis A; Gatehouse PD; Ennis D; Aliotta E; Al-Khalil M; Kellman P; Mazilu D; Balaban RS; Firmin DN; Arai AE; Pennell DJ
    J Am Coll Cardiol; 2017 Feb; 69(6):661-676. PubMed ID: 28183509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of fibrosis in hypertrophic cardiomyopathy: a radiomic study on cardiac magnetic resonance cine imaging.
    Pu C; Hu X; Lv S; Wu Y; Yu F; Zhu W; Zhang L; Fei J; He C; Ling X; Wang F; Hu H
    Eur Radiol; 2023 Apr; 33(4):2301-2311. PubMed ID: 36334102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Predictive Value of Myocardial Native T1 Mapping Radiomics in Dilated Cardiomyopathy: A Study in a Chinese Population.
    Zhang J; Xu Y; Li W; Zhang C; Liu W; Li D; Chen Y
    J Magn Reson Imaging; 2023 Sep; 58(3):772-779. PubMed ID: 36416613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: differential diagnosis and prediction of cardiac outcome.
    Machii M; Satoh H; Shiraki K; Saotome M; Urushida T; Katoh H; Takehara Y; Sakahara H; Ohtani H; Wakabayashi Y; Ukigai H; Tawarahara K; Hayashi H
    Magn Reson Imaging; 2014 Feb; 32(2):118-24. PubMed ID: 24315973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intelligent diagnosis of left ventricular hypertrophy using transthoracic echocardiography videos.
    Xu Z; Yu F; Zhang B; Zhang Q
    Comput Methods Programs Biomed; 2022 Nov; 226():107182. PubMed ID: 36257197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness ≥ 15 mm.
    Rodrigues JC; Rohan S; Ghosh Dastidar A; Harries I; Lawton CB; Ratcliffe LE; Burchell AE; Hart EC; Hamilton MC; Paton JF; Nightingale AK; Manghat NE
    Eur Radiol; 2017 Mar; 27(3):1125-1135. PubMed ID: 27368925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomics and deep learning for myocardial scar screening in hypertrophic cardiomyopathy.
    Fahmy AS; Rowin EJ; Arafati A; Al-Otaibi T; Maron MS; Nezafat R
    J Cardiovasc Magn Reson; 2022 Jun; 24(1):40. PubMed ID: 35761339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
    Matoh F; Satoh H; Shiraki K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
    J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Texture analysis and machine learning of non-contrast T1-weighted MR images in patients with hypertrophic cardiomyopathy-Preliminary results.
    Baeßler B; Mannil M; Maintz D; Alkadhi H; Manka R
    Eur J Radiol; 2018 May; 102():61-67. PubMed ID: 29685546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial fibrosis and quality of life in patients with non-ischemic cardiomyopathy: a cardiovascular magnetic resonance imaging study.
    Khan R; Massel D; Stirrat J; Scholl D; Wisenberg G; Thompson T; Drangova M; White JA
    Int J Cardiovasc Imaging; 2013 Feb; 29(2):395-404. PubMed ID: 22875171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological analysis of hypertrophic cardiomyopathy simulating dilated cardiomyopathy.
    Kawashima T; Yokota Y; Yokoyama M; Itoh H
    Acta Pathol Jpn; 1993 Jun; 43(6):304-12. PubMed ID: 8346707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.